We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$245M
AUM Growth
+$31M
Cap. Flow
+$33M
Cap. Flow %
13.48%
Top 10 Hldgs %
7.31%
Holding
511
New
57
Increased
251
Reduced
151
Closed
49

Top Buys

Rank Stock Value
1
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$1.9M
2
COIN icon
Coinbase
COIN
+$1.35M
3
DOCU
DocuSign
DOCU
+$1.32M
4
SPOT icon
Spotify
SPOT
+$1.28M
5
UAL icon
United Airlines
UAL
+$1.28M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$1.14M
2
EXPE icon
Expedia Group
EXPE
+$1.04M
3
KKR icon
KKR & Co
KKR
+$976K
4
CME icon
CME Group
CME
+$974K
5
CPAY icon
Corpay
CPAY
+$948K

Sector Composition

Rank Sector Weight
1 Financials 29.48%
2 Technology 14.86%
3 Healthcare 14.81%
4 Industrials 11.61%
5 Consumer Discretionary 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
201
BioMarin Pharmaceuticals
BMRN
$11.6B
$347K 0.14%
5,277
+1,367
+35% +$91.6K
BBIO icon
202
BridgeBio Pharma
BBIO
$16.5B
$347K 0.14%
12,637
+1,280
+11% +$33.1K
BCRX icon
203
BioCryst Pharmaceuticals
BCRX
$2.43B
$346K 0.14%
46,007
-6,858
-13% -$52.1K
DAWN
204
DELISTED
Day One Biopharmaceuticals
DAWN
$346K 0.14%
27,296
+1,805
+7% +$25.1K
BIIB icon
205
Biogen
BIIB
$29.5B
$344K 0.14%
2,251
+843
+60% +$142K
DVAX
206
DELISTED
Dynavax Technologies
DVAX
$344K 0.14%
26,917
-506
-2% -$6.12K
KNSA icon
207
Kiniksa Pharmaceuticals
KNSA
$4.89B
$343K 0.14%
17,361
-195
-1% -$4.45K
TGTX icon
208
TG Therapeutics
TGTX
$8.53B
$343K 0.14%
11,393
-8,258
-42% -$237K
ZLAB icon
209
Zai Lab
ZLAB
$2.1B
$343K 0.14%
13,086
-3,641
-22% -$101K
MIRM icon
210
Mirum Pharmaceuticals
MIRM
$6.96B
$342K 0.14%
8,270
-4,074
-33% -$170K
SRPT icon
211
Sarepta Therapeutics
SRPT
$1.68B
$342K 0.14%
2,809
+174
+7% +$21.3K
UTHR icon
212
United Therapeutics
UTHR
$26.3B
$341K 0.14%
967
-178
-16% -$65.4K
INCY icon
213
Incyte
INCY
$23.7B
$341K 0.14%
4,937
-317
-6% -$22.6K
APLS
214
DELISTED
Apellis Pharmaceuticals
APLS
$341K 0.14%
10,680
+2,942
+38% +$88.5K
IMCR icon
215
Immunocore
IMCR
$1.72B
$340K 0.14%
11,536
+3,238
+39% +$102K
TVTX icon
216
Travere Therapeutics
TVTX
$5.27B
$340K 0.14%
19,523
-25,967
-57% -$459K
MRNA icon
217
Moderna
MRNA
$22.1B
$340K 0.14%
8,166
+5,898
+260% +$282K
ARDX icon
218
Ardelyx
ARDX
$1.25B
$338K 0.14%
66,728
+15,981
+31% +$88.3K
REGN icon
219
Regeneron Pharmaceuticals
REGN
$69.9B
$336K 0.14%
472
+151
+47% +$127K
ALNY icon
220
Alnylam Pharmaceuticals
ALNY
$37.2B
$336K 0.14%
1,426
-632
-31% -$166K
INSM icon
221
Insmed
INSM
$22.7B
$335K 0.14%
4,853
-491
-9% -$35.4K
SAGE
222
DELISTED
Sage Therapeutics
SAGE
$335K 0.14%
61,668
+33,029
+115% +$202K
TBPH icon
223
Theravance Biopharma
TBPH
$874M
$333K 0.14%
35,426
-2,960
-8% -$26.9K
PTCT icon
224
PTC Therapeutics
PTCT
$6.29B
$333K 0.14%
7,383
-1,542
-17% -$66K
AMGN icon
225
Amgen
AMGN
$203B
$333K 0.14%
1,276
+173
+16% +$51.3K
7 8
9
10 11

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, Virtus ETF Advisers held 511 positions worth $245M, up 15% from $214M the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.

Virtus ETF Advisers deployed $33M of net new capital in Q4 2024, opening 57 new positions and adding to 251 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 19,660 shares worth $1.88M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Applovin, an estimated $1.14M trimmed.

  • Virtus ETF Advisers's largest Q4 2024 buy was State Street SPDR Bloomberg High Yield Bond ETF: 19,660 shares worth $1.88M.
  • Virtus ETF Advisers added most to Eagle Point Credit Company in Q4 2024, an estimated $515K increase.
  • Virtus ETF Advisers's biggest Q4 2024 reduction was Applovin, cutting an estimated $1.14M.
  • Virtus ETF Advisers fully exited Expedia Group in Q4 2024, selling an estimated $1.04M.
  • Virtus ETF Advisers's ten largest holdings make up 7.3% of its $245M portfolio in Q4 2024.
  • Virtus ETF Advisers opened 57 new positions and closed 49 in Q4 2024.
  • Virtus ETF Advisers's portfolio value rose 15% quarter-over-quarter to $245M.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.